Anne Dekeyne

Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo

Mark J. Millan, Anne Dekeyne, Alain P. Gobert · Neuropharmacology · 1998 · 283 citations

Life Sciences, Neuroscience, Pharmacology +12

Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade

Mark J. Millan, Mauricette Brocco, Alain P. Gobert et al. · Psychopharmacology · 2004 · 245 citations

Medicine, Pharmacology, Psychiatry +16

Agonist and antagonist actions of yohimbine as compared to fluparoxan at ?2-adrenergic receptors (AR)s, serotonin (5-HT)1A, 5-HT1B, 5-HT1D and dopamine D2 and D3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states

Mark J. Millan, Adrian Newman‐Tancredi, Val�rie Audinot et al. · Synapse · 2000 · 193 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of α₂‐adrenergic and serotonin_2C receptors: a comparison with citalopram

Mark J. Millan, Alain P. Gobert, Jean‐Michel Rivet et al. · European Journal of Neuroscience · 2000 · 168 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

5‐HT6 receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia

Julie Meffre, Séverine Chaumont‐Dubel, Clotilde Mannoury la Cour et al. · EMBO Molecular Medicine · 2012 · 165 citations · Full text

Medicine, Neuroscience, Psychiatry +16